Results 211 to 220 of about 450,484 (298)

The Enhancement of Abiotic Stress Tolerance in <i>Arabidopsis</i> via Heterologous Overexpression of <i>TcDHN1</i>, a Dehydrin Identified in the Recalcitrant Seeds of <i>Taxillus chinensis</i>. [PDF]

Plants (Basel)
Qin Y, Li Y, Yang C, Liang W, Gui L, Song L, Shen J, Chen R, Pan L, Wei S, Wan L.   +10 more
europepmc   +1 more source

Revisiting Mission‐Oriented Cancer Research to tackle the increasing burden of cancer in Europe–a policy perspective

Molecular Oncology, EarlyView.
Translational cancer research and its implementation through competitively selected Comprehensive Cancer Centers across Europe should be the primary policy focus for addressing the increasing cancer burden in Europe and counteract the present main strategy to convert cancer to a chronic disease.
Manuel Heitor, Julio Celis, Ulrik Ringborg   +2 more
wiley   +1 more source

Understanding the metabolome of four stress-relieving and cognitive-enhancing medicinal plants: a comprehensive HR-LC-ESI-MS/MS analysis. [PDF]

Metabolomics
Khan MN, Shah SMZ, Rahman S, Musharraf SG.   +3 more
europepmc   +1 more source

Insights into a long life without cancer: The case of the bowhead whale

Molecular Oncology, EarlyView.
Long‐lived, large‐bodied organisms have evolved powerful anticancer mechanisms that preserve cellular and tissue integrity across extended lifespans. A recent study by Firsanov et al. shows that greater genome stability is a key factor underlying the remarkable longevity and cancer resistance of one such species, the bowhead whale.
Inés Paniagua, Johanna A. Joyce
wiley   +1 more source

Proteasome inhibitor, ixazomib prevents topoisomerase‐I degradation and reverses irinotecan resistance in colorectal cancer

Molecular Oncology, EarlyView.
Ixazomib inhibits proteasome‐mediated degradation of topoisomerase I induced by irinotecan, thereby restoring drug sensitivity and promoting tumor cell death in colorectal cancer. Irinotecan, a topoisomerase I (topoI) inhibitor, is widely used for colorectal cancer, but resistance remains a major clinical challenge.
Yuho Ebata, Koji Ando, Hirofumi Hasuda, Koshi Mimori, Elizabeth C. Unan, Siddhartha Pulukuri, Aahana Tiku, Allison Berger, Eiji Oki, Ajit Bharti, Tomoharu Yoshizumi   +10 more
wiley   +1 more source

Current Knowledge and Utilization of Medicinal Plants and Fungi in Northeastern Croatia. [PDF]

Plants (Basel)
Krstin L, Katanić Z, Turk I, Gajski I, Pfeiffer TŽ.   +4 more
europepmc   +1 more source

Checkpoint blockade and the stem‐like T cell trade‐off

Molecular Oncology, EarlyView.
Stem‐like T cells are key to the success of programmed cell death protein 1 (PD1) blockade, as they sustain long‐term anti‐tumor response by continuously generating effector CD8+ T cells. However, how these cells are maintained in cancer is not fully understood. Hor et al.
Julie M. Mazet, Johanna A. Joyce
wiley   +1 more source

Indigenous knowledge on the uses and conservation of medicinal plants in Namutumba District, Eastern Uganda. [PDF]

BMC Complement Med Ther
Tugume P, Ssenku JE, Asiimwe S, Mustafa AS, Walusansa A.   +4 more
europepmc   +1 more source

Molecular cancer prevention: Intercepting disease

Molecular Oncology, EarlyView.
Oncological practice must evolve, from treating established tumours to proactive cancer interception before clinical manifestation. This will require mechanistic insight into tumour initiation, validated biomarkers of early disease development and redesigned clinical trials, enabling cancer interception to become a core pillar of oncology with the ...
Charlotte Grieco, Tej Pandya, Charles Swanton   +2 more
wiley   +1 more source

The Influence of the Environment and the Use of Woody Plants: New Evidence for the Ecological Apparency Hypothesis. [PDF]

Environ Manage
de Almeida KC, de Lucena RFP, Monteiro JM.   +2 more
europepmc   +1 more source